Biocure Technology Inc (CURE.CX)
0.015
0.00 (0.00%)
CAD |
CNSX |
May 09, 16:00
Biocure Technology Revenue (Quarterly)
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2019 | -0.0031M |
| September 30, 2019 | 0.0016M |
| June 30, 2019 | 0.0004M |
| March 31, 2019 | |
| December 31, 2018 | -0.0773M |
| Date | Value |
|---|---|
| September 30, 2018 | 0.0751M |
| June 30, 2018 | 0.0022M |
| March 31, 2018 | |
| December 31, 2017 | -0.008M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
-0.0031M
Minimum
Dec 2019
0.0016M
Maximum
Sep 2019
-0.0003M
Average
0.0004M
Median
Jun 2019
Revenue (Quarterly) Benchmarks
| Core One Labs Inc | 0.0937M |
| Nova Mentis Life Science Corp | 0.0283M |
| Nanosphere Health Sciences Inc | -- |
| Lobe Sciences Ltd | 0.1362M |
| Algernon Pharmaceuticals Inc | -- |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -0.1132M |
| Total Expenses (Quarterly) | 0.0549M |
| EPS Diluted (Quarterly) | -0.0014 |
| Enterprise Value | 1.49M |
| Earnings Yield | 171.6% |
| Normalized Earnings Yield | -395.92 |